Epilepsy

Filipa Bastos1, J Helen Cross2

  • 1University College London National Institute of Health Research Biomedical Research Centre, Great Ormond Street Institute of Child Health, and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom; Centre Hospitalier Universitaire de Lausanne, Child Neurology and Neurorehabilitation Unit, University of Lausanne, Lausanne, Switzerland.

Insights

Childhood epilepsy, a common neurological condition, can harm brain development and co-occur with cognitive issues. Accurate diagnosis is crucial for effective treatment and managing expectations for children with epilepsy.

Area of Science:

  • Neurology
  • Pediatrics
  • Developmental Neuroscience

Background:

  • Epilepsy is a chronic neurological disorder with significant neurobiological, cognitive, and psychosocial consequences.
  • It is the most common chronic neurologic condition in childhood, affecting 0.5%-1% globally.
  • Epileptic activity can disrupt normal brain development, frequently coexisting with neurocognitive and behavioral disorders.

Purpose of the Study:

  • To provide a comprehensive overview of childhood epilepsy.
  • To discuss the diagnostic challenges and management strategies.
  • To highlight the importance of accurate diagnosis for treatment and prognosis.

Main Methods:

  • Review of existing literature on childhood epilepsy.
  • Synthesis of information on definition, epidemiology, diagnosis, management, and outcome.
  • Discussion of the impact of epilepsy on brain development.

Main Results:

  • Childhood epilepsy encompasses diverse disorders with varied etiologies, impacting management and outcomes.
  • Accurate phenotypic and etiologic diagnosis is critical for guiding treatment decisions.
  • Understanding the relationship between epilepsy and co-occurring neurocognitive disorders is essential.

Conclusions:

  • Accurate diagnosis is paramount for effective management and setting realistic expectations for children with epilepsy.
  • The field of childhood epilepsy is rapidly evolving, requiring continuous updates in diagnostic and therapeutic approaches.
  • Addressing the complexities of epilepsy in children is vital for optimizing developmental trajectories and quality of life.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
993
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
488
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.4K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
749
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.0K